Airsculpt Technologies Inc (AIRS)vsFresenius Medical Care Corporation (FMS)
AIRS
Airsculpt Technologies Inc
$3.05
+8.16%
HEALTHCARE · Cap: $165.46M
FMS
Fresenius Medical Care Corporation
$22.03
+0.59%
HEALTHCARE · Cap: $12.47B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 12358% more annual revenue ($19.63B vs $157.55M). FMS leads profitability with a 5.0% profit margin vs -11.4%. FMS earns a higher WallStSmart Score of 62/100 (C+).
AIRS
Hold40
out of 100
Grade: F
FMS
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AIRS.
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.03
$68.29 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
2.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : AIRS
The strongest argument for AIRS centers on Price/Book.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bear Case : AIRS
The primary concerns for AIRS are EPS Growth, Market Cap, Debt/Equity.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
AIRS profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
AIRS carries more volatility with a beta of 2.80 — expect wider price swings.
FMS is growing revenue faster at -0.3% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Airsculpt Technologies Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.
Visit Website →Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?